Predictive factors for the recurrence of Cushing’s disease after surgical treatment in childhood
Abstract
Introduction: Cushing’s disease (CD) is a rare cause of hypercortisolaemia caused by excessive adrenocorticotropic hormone (ACTH) excretion by a pituitary adenoma. Data on the predictive factors for the recurrence of the disease are limited in comparison with those for the adult population. The identification of the predictive factors for CD recurrence in patients after surgical treatment in childhood was the aim of the presented study.
Material and methods: A retrospective analysis of 26 CD patients, mean age at the time of diagnosis 13.46 years, treated at the Children’s Memorial Health Institute (CMHI) in the years 1994–2018. Two time points were set at which the follow-up (FU) of patients was finished. The first time point (shorter FU, 24 patients) was set when the patients completed their treatment at the CMHI. The second time point (longer FU, 26 patients) was determined on the basis on the time when adult patients (previous CMHI patients) completed the author’s questionnaire. In the case of the other patients (current CMHI paediatric patients and patients who did not respond to the questionnaire), the latest FU in this second time point was made during the last visit to the CMHI. The predictors of disease recurrence were evaluated by the construction of a logistic regression model and receiver operating characteristics.
Results: The average FU after transsphenoidal pituitary surgery (TSS) of 26 patients was 10.23 years (0.67–24.50). Recurrence of CD occurred in four out of 26 patients (15.4%) after an average time of 3.6 years (0.92–8.08) following definitive treatment. The results of the statistical analysis of potential predictive factors for CD recurrence were not conclusive, with no variables confirmed above the statistical significance threshold of p < 0.05. As regards the longer FU, two potential predictors: mean cortisol level at night (p = 0.10) and max. ACTH level after ovine corticotropin-releasing hormone (oCRH) test (p = 0.10), were the closest to meeting the assumed threshold of statistical significance.
Conclusion: Recurrence of CD may be diagnosed even a long time after its effective treatment. It is possible that cortisol levels at night and ACTH values in oCRH test before TSS may be helpful to predict which patients may experience a recurrence after successful initial treatment. However, further studies on a larger sample are needed to confirm this hypothesis.
Keywords: Cushing’s diseaserecurrencepredictive factorstranssphenoidal pituitary surgery
References
- Nieman LK, Biller BMK, Findling JW, et al. Endocrine Society. Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2015; 100(8): 2807–2831.
- Leinung MC, Kane LA, Scheithauer BW, et al. Long term follow-up of transsphenoidal surgery for the treatment of Cushing's disease in childhood. J Clin Endocrinol Metab. 1995; 80(8): 2475–2479.
- Acharya SV, Gopal RA, Goerge J, et al. Radiotherapy in paediatric Cushing's disease: efficacy and long term follow up of pituitary function. Pituitary. 2010; 13(4): 293–297.
- Storr HL, Savage MO, Chan LF, et al. Advances in the management of paediatric Cushing's disease. Horm Res. 2008; 69(6): 327–333.
- Devoe DJ, Miller WL, Conte FA, et al. Long-term outcome in children and adolescents after transsphenoidal surgery for Cushing's disease. J Clin Endocrinol Metab. 1997; 82(10): 3196–3202.
- Lonser RR, Wind JJ, Nieman LK, et al. Outcome of surgical treatment of 200 children with Cushing's disease. J Clin Endocrinol Metab. 2013; 98(3): 892–901.
- Shah NS, Lila A. Childhood Cushing disease: a challenge in diagnosis and management. Horm Res Paediatr. 2011; 76 Suppl 1: 65–70.
- Batista DL, Oldfield EH, Keil MF, et al. Postoperative testing to predict recurrent Cushing disease in children. J Clin Endocrinol Metab. 2009; 94(8): 2757–2765.
- Alwani RA, de Herder WW, van Aken MO, et al. Biochemical predictors of outcome of pituitary surgery for Cushing's disease. Neuroendocrinology. 2010; 91(2): 169–178.
- Invitti C, Redaelli G, Baldi G, et al. Glucocorticoid receptors in anorexia nervosa and Cushing's disease. Biol Psychiatry. 1999; 45(11): 1467–1471.
- Wagenmakers MA, Boogaarts HD, Roerink SH, et al. Endoscopic transsphenoidal pituitary surgery: a good and safe primary treatment option for Cushing's disease, even in case of macroadenomas or invasive adenomas. Eur J Endocrinol. 2013; 169(3): 329–337.
- Alexandraki KI, Kaltsas GA, Isidori AM, et al. Long-term remission and recurrence rates in Cushing's disease: predictive factors in a single-centre study. Eur J Endocrinol. 2013; 168(4): 639–648.
- Faucz FR, Tirosh A, Tatsi C, et al. Somatic USP8 Gene Mutations Are a Common Cause of Pediatric Cushing Disease. J Clin Endocrinol Metab. 2017; 102(8): 2836–2843.
- Pasternak-Pietrzak K, Moszczyńska E, Roszkowski M, et al. Long-term outcome in patients after treatment for Cushing's disease in childhood. PLoS One. 2019; 14(12): e0226033.
- Batista D, Gennari M, Riar J, et al. An assessment of petrosal sinus sampling for localization of pituitary microadenomas in children with Cushing disease. J Clin Endocrinol Metab. 2006; 91(1): 221–224.
- Chabre O. The difficulties of pseudo-Cushing's syndrome (or "non-neoplastic hypercortisolism"). Ann Endocrinol (Paris). 2018; 79(3): 138–145.
- Findling JW, Raff H. DIAGNOSIS OF ENDOCRINE DISEASE: Differentiation of pathologic/neoplastic hypercortisolism (Cushing's syndrome) from physiologic/non-neoplastic hypercortisolism (formerly known as pseudo-Cushing's syndrome). Eur J Endocrinol. 2017; 176(5): R205–R216.
- Lodish M, Dunn SV, Sinaii N, et al. Recovery of the hypothalamic-pituitary-adrenal axis in children and adolescents after surgical cure of Cushing's disease. J Clin Endocrinol Metab. 2012; 97(5): 1483–1491.
- Albani A, Pérez-Rivas LG, Dimopoulou C, et al. The USP8 mutational status may predict long-term remission in patients with Cushing's disease. Clin Endocrinol (Oxf). 2018 [Epub ahead of print].
- Lindsay JR, Oldfield EH, Stratakis CA, et al. The postoperative basal cortisol and CRH tests for prediction of long-term remission from Cushing's disease after transsphenoidal surgery. J Clin Endocrinol Metab. 2011; 96(7): 2057–2064.
- Sonino N, Zielezny M, Fava GA, et al. Risk factors and long-term outcome in pituitary-dependent Cushing's disease. J Clin Endocrinol Metab. 1996; 81(7): 2647–2652.
![](https://journals.viamedica.pl/plugins/generic/popups/images/icons/close.png)